Don't miss out on the highly anticipated third quarter financial results of Sarepta Therapeutics (NASDAQ: SRPT) set to be unveiled on Wednesday 6th November 2024. Be prepared to seize this valuable opportunity to analyze the company's financial performance after market close.
Financial experts on Wall Street anticipate that the business is set to announce an estimated $0.13 loss per share for the quarter. Furthermore, the company is expected to disclose a total revenue of $409.3 million for this specific period.
In the corresponding quarter of the previous year, the company's earnings report revealed a per-share income of $0.37. This significant amount was attributed to the company's remarkable total revenue of $331.82 million generated during that specific period.
According to analysts on Wall Street, the company's full-year performance is projected to result in a total revenue of $1.75 billion. Additionally, they forecast the earnings per share to hit profit of $1.65 for the fiscal year.
In addition, The firm will review the third quarter financial results on 6th November 2024 at 04:30 PM eastern time, in a conference call with public.
Sarepta Therapeutics (SRPT) shares traded as low as $122.68 and as high as $126.51 on a day volume of 1.14 million shares, closed Friday's regular trading session at $123.29, downfall of 2.15 percent.
